Summit Veterinary Pharmacy has been sold to Swedencare

Summit Veterinary Pharmacy Inc

Summit develops, produces and sells animal health specials exclusively for veterinary professionals in the UK and Hong Kong. Summit’s strong product portfolio, primarily focused on small animals, has recently expanded into the equine sector. Several new products are set to be introduced in the coming years. Summit’s customer base includes over 5,500 veterinary clinics across the UK.

The Deal

With this strategic acquisition, Swedencare has boosted its presence in the rapidly growing animal health specials market. To ensure a seamless transition into the group, founder and former owner Steve Organ will continue to lead Summit for the next two years.

“The Summit team and I are excited to join Swedencare’s growing platform,” said Steve Organ, Director of Summit Veterinary Pharmaceuticals Limited. “Together, Swedencare and Summit will leverage their shared commitment to innovation by delivering best-in-class veterinary medicines and globally elevating the standard of care in veterinary medicine. Our collaboration will ensure that veterinarians have access to the best medicines available, enabling them to provide exceptional care to their patients.”

Our Perspective

“We appreciated the opportunity to represent Summit Veterinary Pharmaceuticals in this milestone transaction and look forward to witnessing its continued growth and success,” commented Roddy O’Neill, Lincoln Managing Director and co-head of Lincoln’s U.S. Healthcare Group who led the transaction. “This marks our fifth transaction in the animal health compounding space and our 60th in the broader animal health space, as we continue to build meaningful partnerships for our clients.”

Swedencare AB

Swedencare develops, produces and sells premium products in the global and rapidly growing pet healthcare market, focusing on cats, dogs and horses. Its extensive product portfolio includes strong brands such as NaturVet®, Innovet, Pet MD®, Rx Vitamins®, nutravet®, Rileys® and ProDen PlaqueOff®. With headquarters in Malmö, its products are sold in approximately 70 countries through veterinarians, pet stores and online. Swedencare’s extensive distribution network consists of subsidiaries in nine countries, along with an international network of retailers. Swedencare has experienced strong growth for several years while maintaining high profitability.

“With this exciting acquisition, we are entering a new segment of the industry that offers ongoing growth opportunities in the UK market and the potential for expanding the business into the EU and other markets in the coming years,” said Håkan Lagerberg, CEO of Swedencare. “The growth potential and strong profitability will position Summit as a key player within the Swedencare family. I am thrilled to welcome Steve and the entire Summit team to our group.”

“Summit has a rich history of innovation and, with this acquisition, will gain access to Swedencare’s patented soft chew technology, offering customers a premium oral solid dosage form,” said John Kane, Director of Production at Swedencare. “Soft chews are in high demand; however, challenges in pharmaceutical technology have previously limited access. With our technology, which is based on over a decade of development and investment, Summit can provide one or more active pharmaceutical ingredients in a highly palatable and stable soft chew formulation.

Share: